The purpose of this study is to learn more about the tolerability and safety of a daily immunotherapy tablet (SLIT-tablet) for people with peanut allergies. The goal of the SLIT-tablet is to increase tolerance to peanut protein, which could reduce the risk of allergic reactions caused by accidental exposure.
If you decide to take part, you will contribute to the development of a peanut SLIT-tablet to benefit patients in the future. If you take part you will be offered the opportunity to take part in a future trial which includes at least 12 months of treatment with the peanut SLIT-tablet. Participation in this study involves lung function tests, completing an eDiary, Oral Food Challenges and blood draws.
Telephone visits $20; In person visits $75-100, Parking Vouchers
Pediatrics - Allergy Immunology and Rheumatology
Clinical or Medical